Dr. Kassabian graduated from the University of Montreal in Montreal, Quebec, in 1985 after brief clerkships at McGill University and the Massachusetts General Hospital of Harvard Medical School. He completed his urologic residency at the University of Montreal in 1990 and also completed additional training as a research fellow in urologic oncology at Baylor College of Medicine in Houston, Texas in 1991. He later served as clinical instructor of urologic oncology in 1992. Prior to joining Georgia Urology, he was assistant professor of surgery at Emory University. He practiced urologic oncology at Emory University Hospital and each of its affiliated hospitals. He was also Chief of Urology at the V.A. Hospital in Atlanta and served on several committees, including the Cancer Committee and the Peer Review Committee.
During his years in academic medicine, Dr. Kassabian was dedicated to training residents and medical students in urology and was honored with the Teacher of the Year award at Emory for his contribution to excellence in education. Dr. Kassabian has written numerous publications, articles, and book chapters, has made presentations at both national and international meetings, and has lectured extensively on prostate cancer and prostate diseases.
Dr. Kassabian has vast experience in clinical research, especially in prostate cancer. His surgical expertise is in complex oncological cases, advanced prostate cancer, MRI fusion and High Intensity Focused Ultrasound. He is a member of the American Urologic Association, the Canadian Urological Association, LUGPA and the Society of Urologic Oncology. He also serves as Contributing Editor for “Reviews in Urology” and is a reviewer for “Urology Practice”.
Dr. Kassabian is the Medical Director of Georgia Urology, P.A., one of the largest and well known private practice urology groups in the country. He also serves as the urologist member of the Contractor Advisory Committee of CAHABA, the regional Medicare carrier for Georgia.
Urologic Oncology (Cancer of the urinary tract including prostate, kidney, bladder, and testicular) High Intensity Focused Ultrasound (HIFU).
Georgia Urology physicians help Northside Hospital to become metro Atlanta’s first to use new MRI, ultraound system to treat prostate cancer
July 17, 2015Artemis system includes computer-aided detection to assist in biopsies January 13, 2017 (Atlanta) — Physicians from Georgia Urology, the largest urology practice in the Southeastern United States, have played a vital role as Northside Hospital has Read More »
Vahan Kassabian MD, FACS, FRCS Co-chairs Immunotherapy in Genitourinary (GU) Malignancies Plenary
July 17, 2015World renowned faculty including Georgia Urology Medical Director Dr. Vahan Kassabian will share their expertise during interactive sessions, and will present cutting-edge scientific advancements and treatment updates at the Atlanta Cancer Symposium: Read More »
Georgia Urology Launches New HIFU Program
July 17, 2015Dr. Vahan Kassabian’s patient shares his story with 11Alive Georgia Urology’s Dr. Vahan Kassabian was recently featured on 11Alive performing Georgia’s first HIFU prostate cancer treatment. High Intensity Focused Ultrasound (HIFU) uses strong, Read More »
Dr. Vahan Kassabian, MD, FACS, FRCS
July 17, 2015Dr. Vahan Kassabian has recently been named by Cahaba to the Government Benefit Administrations (GBA) Carrier Advisory Committee for Georgia as the Urology Advisor. Cahaba GBA is a regional Medicare benefits contractor which provides administrative Read More »
FDA approves new HIFU procedure for prostate tissue ablation
July 17, 2015The FDA has approved HIFU, or high intensity focused ultrasound, for prostate tissue ablation. Georgia Urology’s Dr. Vahan Kassabian is the only Atlanta-area expert in this procedure. He has vast experience performing the procedure for many Read More »